Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €41.76 | €67.64 | 61.971% |
| Palisade Bio Inc. | 3 | 1 | 2 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €37.60 | €50.00 | 32.979% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.55 | - | - |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.31 | - | - |
| Agenus Inc. | 3 | 2 | 1 | 0 | €0.41 | €22.25 | 5276.897% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.66 | - | - |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €7.55 | €7.00 | -7.285% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €2.25 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.87 | €30.00 | 945.296% |
| Ironwood Pharmaceuticals | 8 | 1 | 1 | 0 | €6.30 | €18.80 | 198.367% |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Vaxart Inc. | 0 | 1 | 0 | 0 | €0.82 | - | - |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €6.65 | €58.50 | 779.699% |
| Gritstone Oncology Inc | 3 | 2 | 1 | 0 | €0.71 | €6.43 | 801.121% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.50 | €3.00 | 496.421% |
| D.Western Therapeutics Institute Inc | 1 | 1 | 0 | 0 | €0.55 | €1.70 | 211.927% |
| Fibrogen Inc. | 1 | 2 | 0 | 0 | €1.08 | €6.00 | 454.785% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €28.15 | €38.00 | 34.989% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.38 | €7.00 | 194.118% |
| Formycon AG | 3 | 1 | 0 | 0 | €42.90 | €100.00 | 133.100% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €20.44 | €52.03 | 154.525% |